Charles Schwab
CCRN

Charles Schwab’s Cross Country Healthcare CCRN Stock Holding History

Charles Schwab’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.95M Sell
952,125
-17,333
-2% -$155K ﹤0.01% 2157
2025
Q4 		$7.85M Buy
969,458
+211,925
+28% +$2.32M ﹤0.01% 2248
2025
Q3 		$10.8M Buy
757,533
+195,652
+35% +$2.58M ﹤0.01% 2078
2025
Q2 		$7.33M Buy
561,881
+159,651
+40% +$2.19M ﹤0.01% 2157
2025
Q1 		$5.99M Buy
402,230
+87,353
+28% +$1.5M ﹤0.01% 2196
2024
Q4 		$5.72M Sell
314,877
-74,288
-19% -$1M ﹤0.01% 2281
2024
Q3 		$5.23M Sell
389,165
-61,186
-14% -$902K ﹤0.01% 2354
2024
Q2 		$6.23M Sell
450,351
-30,097
-6% -$476K ﹤0.01% 2257
2024
Q1 		$8.99M Buy
480,448
+58,872
+14% +$1.18M ﹤0.01% 2038
2023
Q4 		$9.54M Buy
421,576
+19,689
+5% +$427K ﹤0.01% 2009
2023
Q3 		$9.96M Buy
401,887
+179,093
+80% +$4.51M ﹤0.01% 1907
2023
Q2 		$6.26M Sell
222,794
-17,333
-7% -$430K ﹤0.01% 2142
2023
Q1 		$5.36M Buy
240,127
+8,063
+3% +$211K ﹤0.01% 2175
2022
Q4 		$6.17M Buy
232,064
+17,553
+8% +$573K ﹤0.01% 2111
2022
Q3 		$6.09M Buy
214,511
+49,236
+30% +$1.27M ﹤0.01% 2115
2022
Q2 		$3.44M Buy
165,275
+42,349
+34% +$793K ﹤0.01% 2355
2022
Q1 		$2.66M Buy
122,926
+29,773
+32% +$646K ﹤0.01% 2550
2021
Q4 		$2.59M Buy
93,153
+3,939
+4% +$95.5K ﹤0.01% 2618
2021
Q3 		$1.9M Buy
89,214
+458
+0.5% +$8.59K ﹤0.01% 2710
2021
Q2 		$1.47M Buy
88,756
+1,730
+2% +$26.4K ﹤0.01% 2808
2021
Q1 		$1.09M Sell
87,026
-2,524
-3% -$26.8K ﹤0.01% 2825
2020
Q4 		$795K Hold
89,550
– – ﹤0.01% 2838
2020
Q3 		$582K Sell
89,550
-3,167
-3% -$20.1K ﹤0.01% 2837
2020
Q2 		$572K Buy
92,717
+2,393
+3% +$14.7K ﹤0.01% 2778
2020
Q1 		$609K Sell
90,324
-113
-0.1% -$1.07K ﹤0.01% 2646
2019
Q4 		$1.05M Sell
90,437
-1,991
-2% -$22.5K ﹤0.01% 2581
2019
Q3 		$953K Buy
92,428
+4,515
+5% +$44.4K ﹤0.01% 2582
2019
Q2 		$825K Hold
87,913
– – ﹤0.01% 2639
2019
Q1 		$619K Buy
87,913
+2,356
+3% +$20.2K ﹤0.01% 2688
2018
Q4 		$628K Buy
85,557
+4,342
+5% +$36.4K ﹤0.01% 2686
2018
Q3 		$710K Buy
81,215
+6,000
+8% +$61.3K ﹤0.01% 2722
2018
Q2 		$847K Hold
75,215
– – ﹤0.01% 2636
2018
Q1 		$836K Hold
75,215
– – ﹤0.01% 2575
2017
Q4 		$960K Hold
75,215
– – ﹤0.01% 2516
2017
Q3 		$1.07M Hold
75,215
– – ﹤0.01% 2489
2017
Q2 		$972K Buy
75,215
+12,900
+21% +$166K ﹤0.01% 2469
2017
Q1 		$895K Buy
62,315
+600
+1% +$8.83K ﹤0.01% 2454
2016
Q4 		$964K Sell
61,715
-8,891
-13% -$122K ﹤0.01% 2439
2016
Q3 		$832K Hold
70,606
– – ﹤0.01% 2453
2016
Q2 		$983K Sell
70,606
-11,754
-14% -$156K ﹤0.01% 2353
2016
Q1 		$958K Buy
82,360
+20,645
+33% +$262K ﹤0.01% 2363
2015
Q4 		$1.01M Hold
61,715
– – ﹤0.01% 2383
2015
Q3 		$840K Hold
61,715
– – ﹤0.01% 2443
2015
Q2 		$783K Sell
61,715
-10,644
-15% -$121K ﹤0.01% 2518
2015
Q1 		$859K Buy
72,359
+20,209
+39% +$232K ﹤0.01% 2426
2014
Q4 		$651K Sell
52,150
-13,000
-20% -$133K ﹤0.01% 2528
2014
Q3 		$606K Buy
65,150
+15,450
+31% +$118K ﹤0.01% 2519
2014
Q2 		$325K Hold
49,700
– – ﹤0.01% 2822
2014
Q1 		$402K Hold
49,700
– – ﹤0.01% 2682
2013
Q4 		$497K Hold
49,700
– – ﹤0.01% 2589
2013
Q3 		$303K Hold
49,700
– – ﹤0.01% 2740
2013
Q2 		$261K Buy
+49,700
New +$255K ﹤0.01% 2785

Other funds holding CCRN

Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab's CCRN Position: Q1 2026 in Review

Charles Schwab reduced its Cross Country Healthcare (CCRN) stake by 1.8% in Q1 2026, selling an estimated $155K and leaving 952,125 shares worth $8.95M. The position accounts for ﹤0.01% of the portfolio, ranked #2157.

Charles Schwab first reported a position in CCRN in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.8M in Q3 2025. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.

  • Charles Schwab held 952,125 shares of Cross Country Healthcare worth $8.95M as of Q1 2026.
  • Charles Schwab sold 17,333 Cross Country Healthcare shares in Q1 2026, an estimated $155K.
  • Cross Country Healthcare made up ﹤0.01% of Charles Schwab's portfolio in Q1 2026, its #2157 holding.
  • Charles Schwab first reported a position in Cross Country Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Charles Schwab's Cross Country Healthcare position peaked at $10.8M in Q3 2025.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.

Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.